Rising prevalence of acne among the global population is fueling the demand for acne medications. Increasing awareness about skincare and beauty standards is also contributing to the growth of the acne medication market. Additionally, the availability of advanced treatment options and technological advancements in the field are driving the market further.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Routes of Administration, Age-group, Distribution Channel |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Galderma S.A., Bausch Health Companies, Mayne Pharma Group Limited, Teva Pharmaceutical Industries, Almirall Sa, Glaxosmithkline Plc, Pfizer, Mylan N.V., Sun Pharmaceutical Industries Limited, Johnson & Johnson |
The stringent regulatory requirements and approval processes pose as major restraints for companies operating in the acne medication market. Furthermore, the presence of alternative therapies and home remedies for acne treatment is hindering the growth of the market.